Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Optimized Pacing Eases oHCM Symptoms in EMORI-HCM Trial
Added: 2 months ago Source:  Radcliffe Cardiology
For patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM), the net effect of right ventricular pacing (RVP) has been variable. A new trial suggests that personalising the therapy by electromechanically optimising the atrio-ventricular delay (AVD) can provide a net benefit for symptoms and exercise capacity.¹Right ventricular pacing can reduce the left ventricular outflow tract… View more

Electrophysiology & Arrhythmia

Heart Failure
POTCAST: Raising Potassium Levels Reduces Arrhythmia Risk in ICD Patients
Added: 6 months ago Source:  Arrhythmia Academy
A strategy of actively increasing plasma potassium to high-normal levels significantly lowered the risk of arrhythmia events in high-risk patients with an implantable cardioverter–defibrillator (ICD), according to results from the POTCAST trial.¹˒² The findings were presented at the European Society of Cardiology (ESC) Congress 2025 and simultaneously published in the New England Journal of… View more

Electrophysiology & Arrhythmia

Heart Failure
What’s Hot at ACC.26: Preview with Dr Latib & Prof Van Mieghem
Author(s): Nicolas M Van Mieghem , Azeem Latib Added: 1 month ago
What’s Hot at ACC.26: in this focused preview, Dr Azeem Latib (Montefiore Medical Center, US) and Prof Nicolas Van Mieghem, MD, PhD, pick out the late‑breaking clinical trials at ACC.26 that are most likely to influence practice for operators heading to New Orleans. In a fast, conversational format, they move from pulmonary embolism and left atrial appendage closure to heart failure, STEMI… View more

Imaging & Diagnostics

Intervention
Prevention: What's New at HFA 2025?
Author(s): Harriette Van Spall , Maja Cikes Added: 10 months ago
ESC HF 25 - Join experts, Dr Harriette Van Spall (McMaster University, CA) and Dr Maja Cikes (University Hospital Centre Zagreb, HR) for an insightful wrap up of the novel data concerning preventive cardiology that was presented at 2025's Heart Failure Congress.Trials discussed include:REDICAE (00:42)FINEARTS HF (02:27)CRISPR Gene Editing with Nexiguran Ziclumeran (05:53)HELIOS B (07:12)RESHAPE… View more

Heart Failure
ESC HFA 25: SCD-PROTECT
Author(s): Johann Bauersachs Added: 10 months ago
ESC HF 25 - SCD-PROTECT shows high risk of sudden cardiac arrest (SCA) and sudden cardiac death (SCD) during early medical therapy optimization for reduced LVEF in patients with new non-ischemic cardiomyopathy or MI/CAD.Prof Johann Bauersachs (Hannover Medical School, Hannover, DE) discusses findings from the SCD–PROTECT study, an investigation of sudden cardiac arrest in patients with newly… View more

MI/ACS

Heart Failure
e-SPACE Heart Failure 2025
Author(s): William T Abraham, Lisa Anderson, Stefan Anker Start date: Oct 18, 2025
e-SPACE Heart Failure 2025 will once again offer high-quality, free virtual education – maximising global reach while delivering both international and regional perspectives. The expertly designed programme will delve into how leading clinicians are translating heart failure guidelines into real-world practice and will provide the latest insights into patient profiling for personalised heart… View more

Heart Failure
e-SPACE Heart Failure 2025
Author(s): William T Abraham, Lisa Anderson, Stefan Anker Start date: Oct 17, 2025
e-SPACE Heart Failure 2025 will once again offer high-quality, free virtual education – maximising global reach while delivering both international and regional perspectives. The expertly designed programme will delve into how leading clinicians are translating heart failure guidelines into real-world practice and will provide the latest insights into patient profiling for personalised heart… View more

Heart Failure
PAP Therapies for HF: What Do the Trials Tell Us?
Author(s): Jan Pec , Michael Arzt Added: 4 months ago

Guidelines & Statements

Heart Failure
Late-Breaking Clinical Trial Presentations for Heart Failure Congress 2024 Revealed
Added: 1 year ago Source:  Heart Failure 2024
Heart Failure Congress 2024 has unveiled 8 Late-breaking trial sessions for 2024.Heart Failure 2024 will take place at the Lisbon Congress Center in May. Access the full Programme here.For quick and practical summaries of the late-breaking trials, watch our 5-minute Expert Interviews conducted with the investigators, and keep up to date with our Late-Breaker Discussions with Dr Van Spall.Late… View more

Heart Failure
Reverse Remodelling, Myocardial Recovery and Remission in Heart Failure with Reduced Ejection Fraction: Clinical Implications and Management Strategies
Author(s): Silas Ramos Furquim , Maria Tereza Sampaio de Sousa Lira , Deborah de Sá Pereira Belfort , et al Added: 4 months ago

Guidelines & Statements

Heart Failure